WHO / EU “Bad Medicine” Plans: Flaws, Coordination Gaps 02/04/2012 by Intellectual Property Watch 2 Comments The latest World Health Organization / European Union plans to counter the trade in counterfeit and substandard medicines aim to ensure that medicines in the developing world are safe. As such, though both plans appropriately address quality issues, they fall short of adequate coordination and collaboration with each other, and also present substantial flaws, Daniele Dionisio writes.